EGF and glioblastoma: Our studies show that the cardiac glycoside and specific inhibitor of Na,K-ATPase, ouabain, can inhibit EGF-induced signaling and cell migration in medulloblastoma cells, but not glioblastoma cells, and indeed support the notion of developing novel therapeutic approaches targeting the sodium pump.